Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
H.I.G. BioVentures is a growth equity fund based globally, focusing on healthcare investments. The firm has a seasoned investment team with extensive experience in pharmaceuticals, biotechnology, and medical devices. They have invested in over 400 companies, with a significant number in healthcare.
This firm primarily invests in medical devices, biopharmaceuticals, digital health tools, diagnostics, and related services. H.I.G. BioVentures engages in go-to-market strategies, management recruitment, and operational excellence post-investment. Their goal is to achieve liquidity through M&A or IPO while improving patient outcomes.
Notable companies in H.I.G. BioVentures' portfolio include Alder Biopharmaceuticals, Arvelle Therapeutics, Augmedics, BIOVECTRA, Celerion, Click Therapeutics, Exagen, ForSight VISION5, Highridge Medical, HyperBranch Medical Technology, Intact Vascular, Navitas Life Sciences, RxSight, and Zerigo Health.
Submit through their form at highealthbridge.com.
Yes, H.I.G. BioVentures often leads investment rounds in growth-stage healthcare companies.
The firm provides follow-on financing options to support portfolio companies as they grow and scale.
Specific fund size details are not disclosed, but the firm has a significant portfolio with over 400 companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.